CAPTAIN:Choroidal Neovascularization Assessment by Pattern Electroretinography
Status:
Completed
Trial end date:
2009-03-01
Target enrollment:
Participant gender:
Summary
CNV from AMD is the leading cause of blindness in people over 50 in North America. The
hypothesis is to determine if there is an improvement in retinal function determined by ERG
following treatment with ranibizumab for AMD